Predicting responses to chemotherapy in breast cancer: from bench to bedside

被引：0
|
作者：
Akashi-Tanaka, Sadako [1 ]
机构：
[1] Natl Canc Ctr, Div Breast Surg, Chuo Ku, Tokyo 1040045, Japan
来源：
BREAST CANCER | 2010年 / 17卷 / 02期
关键词：
Breast cancer; Predictive factor; Gene expression profile; Chemotherapy; Pharmacogenomics; GENE-EXPRESSION; NEOADJUVANT CHEMOTHERAPY; DOCETAXEL; EFFICACY; THERAPY; TRASTUZUMAB; SUBTYPES; MARKER; WOMEN; TRIAL;
D O I：
10.1007/s12282-009-0166-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent progress in biotechnology, notably microarray analyses, makes it possible to examine the genome-based characteristics of tumors with different prognoses and predict responses to chemotherapy. Furthermore, pharmacogenomic techniques are expected to predict the optimal regimen for individual patients that will provide high benefits with reduced toxicity. Some predictive or prognostic tests for breast cancer are now moving from bench to bedside.
引用
收藏
页码：92 / 96
页数：5
相关论文
共 50 条
  • [1] Predicting responses to chemotherapy in breast cancer: from bench to bedside
    Sadako Akashi-Tanaka
    Breast Cancer, 2010, 17 : 92 - 96
  • [2] Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again?
    Saleh, R. R.
    Bouganim, N.
    Hilton, J.
    Arnaout, A.
    Clemons, M.
    CURRENT ONCOLOGY, 2014, 21 (01) : E122 - E128
  • [3] Exosomes in triple negative breast cancer: From bench to bedside
    Tang, Weiqiang
    Xia, Min
    Liao, Yajie
    Fang, Yuan
    Wen, Gebo
    Zhong, Jing
    CANCER LETTERS, 2022, 527 : 1 - 9
  • [4] Neoadjuvant chemotherapy in breast cancer: what questions remain?
    Sulpher, Jeffrey
    Dent, Rebecca
    Dent, Susan
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2014, 8 (01) : 59 - 63
  • [5] Androgen Receptor in Breast Cancer: From Bench to Bedside
    Chen, Mengyao
    Yang, Yunben
    Xu, Kai
    Li, Lili
    Huang, Jian
    Qiu, Fuming
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [6] Immunological Mechanisms in Breast Cancer - from Bench to Bedside
    Denkert, Carsten
    Schuetz, Florian
    BREAST CARE, 2016, 11 (02) : 93 - 94
  • [7] The Dawning of Translational Breast Cancer: From Bench to Bedside
    Chen, Xueman
    Fan, Siting
    Song, Erwei
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 1 - 25
  • [8] Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From laboratory bench to bedside
    de Bree, Eelco
    Theodoropoulos, Panayiotis A.
    Rosing, Hilde
    Michalakis, John
    Romanos, John
    Beijnen, Jos H.
    Tsiftsis, Dimitris D.
    CANCER TREATMENT REVIEWS, 2006, 32 (06) : 471 - 482
  • [9] Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond
    Sinha, Dona
    Biswas, Jaydip
    Nabavi, Seyed Mohammad
    Bishayee, Anupam
    SEMINARS IN CANCER BIOLOGY, 2017, 46 : 33 - 54
  • [10] Cyclin kinase inhibitors in breast cancer: From bench to bedside
    Torres G.
    Echavarría I.
    Lobo M.
    Márquez-Rodas I.
    Martin M.
    Current Breast Cancer Reports, 2014, 6 (2) : 79 - 87
12345